"Batai Medical" completes nearly 200 million yuan in Series D financing

36Kr learned that recently, Bate Medical announced the completion of a Series D financing of nearly 200 million yuan. This round was led by Chuangdong Investment, with co-investments from Zhejiang "4+1" Biomedicine and High-End Device Industry Fund, E-Fund Capital, Zhongyiren Capital, and individual industrial investors. Existing shareholder Junxingjian Capital continued to increase its investment, and Qifeng Capital provided financing support. The proceeds from this round will mainly be used for the commercial promotion and clinical evidence accumulation of Bate Medical's third-generation constrained drug-coated balloon, the expansion of a new intelligent production base, and the R&D of subsequent innovative vascular interventional products.